In a demyelination mouse model, the administration of etazolate, a sAPPα promoter, restored damaged myelin, increased myelin basic protein (MBP) and mature oligodendrocytes (OLs), and provided protection against further demyelination (Llufriu-Dabén et al., 2018). The gene discussed is MBP; the disease is Peripheral demyelination.